Mednax Inc Stock Market Value
MD Stock | USD 14.76 0.20 1.34% |
Symbol | Mednax |
Mednax Inc Price To Book Ratio
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mednax. If investors know Mednax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mednax listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.11) | Earnings Share (2.34) | Revenue Per Share 24.174 | Quarterly Revenue Growth 0.009 | Return On Assets 0.0467 |
The market value of Mednax Inc is measured differently than its book value, which is the value of Mednax that is recorded on the company's balance sheet. Investors also form their own opinion of Mednax's value that differs from its market value or its book value, called intrinsic value, which is Mednax's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mednax's market value can be influenced by many factors that don't directly affect Mednax's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mednax's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mednax is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mednax's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Mednax 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Mednax's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Mednax.
10/26/2024 |
| 11/25/2024 |
If you would invest 0.00 in Mednax on October 26, 2024 and sell it all today you would earn a total of 0.00 from holding Mednax Inc or generate 0.0% return on investment in Mednax over 30 days. Mednax is related to or competes with Acadia Healthcare, Select Medical, Universal Health, Prestige Brand, and US Physicalrapy. Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, a... More
Mednax Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Mednax's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Mednax Inc upside and downside potential and time the market with a certain degree of confidence.
Downside Deviation | 1.82 | |||
Information Ratio | 0.11 | |||
Maximum Drawdown | 27.59 | |||
Value At Risk | (2.85) | |||
Potential Upside | 3.63 |
Mednax Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Mednax's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Mednax's standard deviation. In reality, there are many statistical measures that can use Mednax historical prices to predict the future Mednax's volatility.Risk Adjusted Performance | 0.1205 | |||
Jensen Alpha | 0.3026 | |||
Total Risk Alpha | (0.05) | |||
Sortino Ratio | 0.2142 | |||
Treynor Ratio | 0.2967 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Mednax's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Mednax Inc Backtested Returns
Mednax appears to be not too volatile, given 3 months investment horizon. Mednax Inc has Sharpe Ratio of 0.14, which conveys that the firm had a 0.14% return per unit of risk over the last 3 months. By analyzing Mednax's technical indicators, you can evaluate if the expected return of 0.51% is justified by implied risk. Please exercise Mednax's Downside Deviation of 1.82, mean deviation of 1.99, and Risk Adjusted Performance of 0.1205 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Mednax holds a performance score of 11. The company secures a Beta (Market Risk) of 1.72, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Mednax will likely underperform. Please check Mednax's downside variance, day median price, and the relationship between the treynor ratio and kurtosis , to make a quick decision on whether Mednax's current price movements will revert.
Auto-correlation | -0.63 |
Very good reverse predictability
Mednax Inc has very good reverse predictability. Overlapping area represents the amount of predictability between Mednax time series from 26th of October 2024 to 10th of November 2024 and 10th of November 2024 to 25th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Mednax Inc price movement. The serial correlation of -0.63 indicates that roughly 63.0% of current Mednax price fluctuation can be explain by its past prices.
Correlation Coefficient | -0.63 | |
Spearman Rank Test | -0.24 | |
Residual Average | 0.0 | |
Price Variance | 0.24 |
Mednax Inc lagged returns against current returns
Autocorrelation, which is Mednax stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Mednax's stock expected returns. We can calculate the autocorrelation of Mednax returns to help us make a trade decision. For example, suppose you find that Mednax has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
Mednax regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Mednax stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Mednax stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Mednax stock over time.
Current vs Lagged Prices |
Timeline |
Mednax Lagged Returns
When evaluating Mednax's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Mednax stock have on its future price. Mednax autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Mednax autocorrelation shows the relationship between Mednax stock current value and its past values and can show if there is a momentum factor associated with investing in Mednax Inc.
Regressed Prices |
Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Mednax Correlation, Mednax Volatility and Mednax Alpha and Beta module to complement your research on Mednax. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Mednax technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.